These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32944017)

  • 1. Large-scale production, purification, and function of a tumor multi-epitope vaccine: Peptibody with bFGF/VEGFA.
    Zhang L; Jiang C; Chen X; Gu J; Song Q; Zhong H; Xiong S; Dong Q; Yu JC; Deng N
    Eng Life Sci; 2020 Sep; 20(9-10):422-436. PubMed ID: 32944017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Design, Characterizations, and Tumor Angiogenesis Inhibition of a Multi-Epitope Peptibody With bFGF/VEGFA.
    Zhang L; Deng Y; Zhang Y; Liu C; Zhang S; Zhu W; Tang Y; Deng N
    Front Oncol; 2020; 10():1190. PubMed ID: 32766160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fermentation, purification and immunogenicity of a recombinant tumor multi-epitope vaccine, VBP3.
    Zhang L; Chen X; Deng Y; Jiang C; Deng N
    Protein Expr Purif; 2020 Oct; 174():105658. PubMed ID: 32360598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble production and function of vascular endothelial growth factor/basic fibroblast growth factor complex peptide.
    Zhang Q; Lao X; Huang J; Zhu Z; Pang L; Tang Y; Song Q; Huang J; Deng J; Deng N; Yang Q; Sengupta AM; Xiong L
    Biotechnol Prog; 2015; 31(1):194-203. PubMed ID: 25271020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retraction: The Design, Characterizations, and Tumor Angiogenesis Inhibition of a Multi-Epitope Peptibody With bFGF/VEGFA.
    Frontiers Editorial Office
    Front Oncol; 2020; 10():644690. PubMed ID: 33585261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. lncRNA LOC100132354 promotes angiogenesis through VEGFA/VEGFR2 signaling pathway in lung adenocarcinoma.
    Wang Y; Zhang F; Wang J; Hu L; Jiang F; Chen J; Chen J; Wang L
    Cancer Manag Res; 2018; 10():4257-4266. PubMed ID: 30323681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-step chromatographic procedure for purification of basic fibroblast growth factor from recombinant Escherichia coli and characterization of the equilibrium parameters of adsorption.
    Seeger A; Rinas U
    J Chromatogr A; 1996 Oct; 746(1):17-24. PubMed ID: 8885384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational Design of Antiangiogenic Peptibody by Fusing Human IgG1 Fc Fragment and HRH Peptide: Structural Modeling, Energetic Analysis, and Dynamics Simulation of Its Binding Potency to VEGF Receptor.
    Ning L; Li Z; Bai Z; Hou S; He B; Huang J; Zhou P
    Int J Biol Sci; 2018; 14(8):930-937. PubMed ID: 29989101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rhodostomin, a snake venom disintegrin, inhibits angiogenesis elicited by basic fibroblast growth factor and suppresses tumor growth by a selective alpha(v)beta(3) blockade of endothelial cells.
    Yeh CH; Peng HC; Yang RS; Huang TF
    Mol Pharmacol; 2001 May; 59(5):1333-42. PubMed ID: 11306719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basic fibroblast growth factor induces VEGF expression in chondrosarcoma cells and subsequently promotes endothelial progenitor cell-primed angiogenesis.
    Tzeng HE; Chen PC; Lin KW; Lin CY; Tsai CH; Han SM; Teng CL; Hwang WL; Wang SW; Tang CH
    Clin Sci (Lond); 2015 Jul; 129(2):147-58. PubMed ID: 25735814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
    Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-induced retinal pigment epithelium cell-derived bFGF promotes the migration and angiogenesis of HUVECs through regulating TGF-β1/smad2/3 pathway.
    Chen W; He S; Xiang D
    Gene; 2021 Jul; 790():145695. PubMed ID: 33964379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition activity of a disulfide-stabilized diabody against basic fibroblast growth factor in lung cancer.
    Cai Y; Yao S; Zhong J; Zhang J; Jiang H; Deng Y; Deng N
    Oncotarget; 2017 Mar; 8(12):20187-20197. PubMed ID: 28423625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways.
    Gao F; Vasquez SX; Su F; Roberts S; Shah N; Grijalva V; Imaizumi S; Chattopadhyay A; Ganapathy E; Meriwether D; Johnston B; Anantharamaiah GM; Navab M; Fogelman AM; Reddy ST; Farias-Eisner R
    Integr Biol (Camb); 2011 Apr; 3(4):479-89. PubMed ID: 21283904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GNA11 differentially mediates fibroblast growth factor 2- and vascular endothelial growth factor A-induced cellular responses in human fetoplacental endothelial cells.
    Zou QY; Zhao YJ; Li H; Wang XZ; Liu AX; Zhong XQ; Yan Q; Li Y; Zhou C; Zheng J
    J Physiol; 2018 Jun; 596(12):2333-2344. PubMed ID: 29659033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of Shendan Sanjie capsule on angiogenesis in mice with colitis associated cancer and mechanism].
    Xie LS; Huan T; Yang JL; Wu J; Zhao P
    Zhonghua Zhong Liu Za Zhi; 2021 Nov; 43(11):1170-1176. PubMed ID: 34794219
    [No Abstract]   [Full Text] [Related]  

  • 17. Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor.
    Mandriota SJ; Pepper MS
    J Cell Sci; 1997 Sep; 110 ( Pt 18)():2293-302. PubMed ID: 9378778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basic fibroblast growth factor blockade enhances lung cancer cell invasion by activating the AKT/MMP-2/VEGF pathway.
    Wang Z; Xu H; Zhang J; Jin H; Wei P
    Basic Clin Pharmacol Toxicol; 2020 Jan; 126(1):43-50. PubMed ID: 31314153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gekko-sulfated glycopeptide inhibits tumor angiogenesis by targeting basic fibroblast growth factor.
    Zhang SX; Zhu C; Ba Y; Chen D; Zhou XL; Cao R; Wang LP; Ren Y; Wu XZ
    J Biol Chem; 2012 Apr; 287(16):13206-15. PubMed ID: 22371501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between 8-hydroxyquinoline ruthenium(II) complexes and basic fibroblast growth factors (bFGF): inhibiting angiogenesis and tumor growth through ERK and AKT signaling pathways.
    Yang L; Zhang J; Wang C; Qin X; Yu Q; Zhou Y; Liu J
    Metallomics; 2014 Mar; 6(3):518-31. PubMed ID: 24336978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.